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Objectives. Although non-invasive ventilation (NIV) can benefit survival and quality of
life, it is rejected by a substantial proportion of people with motor neurone disease
(MND). The aim of this study was to understand why some MND patients decline or
withdraw from NIV.
Method. Nine patients with MND (male = 7, mean age = 67 years) participated in this
study. These patients, from a cohort of 35 patients who were offered NIV treatment to
support respiratory muscle weakness, did not participate in NIV treatment when it was
clinically appropriate. Semi-structured interviews and interpretative phenomenological
analysis (IPA) were employed to explore these patient’s experience of MND and their
thoughts and understanding of NIV treatment.
Results. Using IPA, four themes were identified: preservation of the self, negative
perceptions of NIV, negative experience with health care services, and not needing
NIV. Further analysis identified the fundamental issue to be the maintenance of
perceived self, which was interpreted to consist of the sense of autonomy, dignity,
and quality of life.
Conclusions. The findings indicate psychological reasons for disengagement with NIV.
The threat to the self, the sense of loss of control, and negative viewsofNIV resulting from
anxiety were more important to these patients than prolonging life in its current form.
These findings suggest the importance of understanding the psychological dimension
involved in decision-making regarding uptake of NIV and a need for sensitive holistic
evaluation if NIV is declined.
Statement of contribution
What is already known on this subject?
 Non-invasive ventilation is widely used as an effective symptomatic therapy in MND, yet about a
third of patients decline the treatment.
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 Psychological disturbance generated by NIV use leads to negative experiences of the treatment.
 Decision-making about treatment potentials is complex and unique to each individual affected by
perceived impact of disease.
What does this study add?
 A decision concerning NIV uptake was influenced by perceived impact on individuals’ sense of self.
 Sense of self was influenced by the maintenance of autonomy, dignity, and quality of life.
 Individuals’ sense of self was identified to have been challenged by the disease, NIV, and their
experience of health care service.
Motor neurone disease (MND), also known as amyotrophic lateral sclerosis (ALS), is a fatal
neurodegenerative disease indicative of the loss of uppermotorneurons (UMN) and lower
motor neurons (LMN; Kiernan et al., 2011). The clinical features of UMN are moderate
weakness, hyperreflexia, pathological reflexes, pseudobulbar affect (emotional lability;
sudden and uncontrollable episodes of crying and/or laughing), spasticity, loss of
dexterity with hands, and slowed movements (Strong & Rosenfeld, 2003). The clinical
features for LMN involve severe weakness, hyporeflexia, muscle atrophy, fasciculations,
muscle cramps, and decreasedmuscle tone (Strong& Rosenfeld, 2003). AlthoughMND is
primarily a disease of motor system degeneration, it is now recognized that there are
overlaps between MND and frontotemporal dementia from pathological, clinical, and
genetic perspectives (Neumann et al., 2006; Phukan, Pender, & Hardiman, 2007). In the
overall MND population, about 50% of patients die within 30 months of the onset and
about 20% of patients survive between 5 and 10 years after the symptom onset (Talbot,
2009).
There is currently no cure for MND; however, various symptomatic therapies are
useful and are offered to patients. The domain of potential therapies includes educational,
pharmacological, and psychological interventions and the supply of medical equipment,
such as non-invasive ventilation (NIV). Addressing respiratory issues is important as most
deaths in MND are caused by pulmonary complications (Andrews, 2009; Winhammar,
Rowe, Henderson, & Kierman, 2005). NIV is the treatment of choice to assist respiratory
effort, and it increases life span, however, with little survival benefit for individuals with
severe bulbar impairment (Bourke et al., 2006).NIV iswidely recommended as a standard
treatment (Andrews, 2009; Phukan & Hardiman, 2009), and the recent survey in the
United Kingdom showed an increased number of patients with MND using NIV (O’Neil
et al., 2012).
Non-invasive ventilation is also widely recognized to improve patients’ quality of life
(Bourke et al., 2006; Sundling, Ekman, Weinberg, & Klefbeck, 2009). However, ‘quality of
life’ is a generalized concept, and there is a lack of consensus on its component parts (Cella,
1994). It isoftenmeasuredquantitatively thus falling short of reflectingadetailed idiographic
account, especially of those categorized as ‘uncommon’. This becomes a particularly
important concept where patients do not take up NIV, raising the question: ‘What are the
dimensions of quality of life of those who decline a treatment known to be beneficial?’ This
study reports an investigation into the experience of those who decline the treatment
towards achieving a better understanding of the full impact of NIV treatment in MND.
Experiences of NIV
Previous studies of NIV have mainly focused on benefits of the treatment, and these
benefits are often measured by means of comparison between NIV users and non-users
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(Lo Coco et al., 2006;Mustfa et al., 2006; Sivak, Shefner, Mitsumoto, & Taft, 2001).While
these studies acknowledge that NIV is not always tolerated or accepted, little attention has
been paid to exploring the factors, leading up to the decision to use NIV. While there is
some evidence that a supportive caregiver is required for uptake of NIV treatment
(Cousins et al., 2013) to date, there remains a lack of a full account of reasons for not
accepting NIV treatment. Moreover, this is particularly of interest where individuals have
initially been willing to use NIV for their condition, yet later decline, as it was for some of
the participants in the current study.
Although previous studies do not provide sufficient reasons for declining or
withdrawing from NIV, unfavourable features of NIV have been identified by studies
exploring the experience of people already establishedwithNIV (Lemoignan&Ells, 2010;
Lindahl, Sandman, & Rasmussen, 2005). Studies exploring the experience of NIV in
various conditions, including MND, seem to agree that both a burden and a relief are
associated with NIV usage. Some of the reported negative experiences of NIV are feelings
of being in a vacuumcleaner bag, being exposed to air pollution, and following the rhythm
ofNIV rather than themachine following the individual’s breathingpattern (Lindahl et al.,
2005). One prominent feature among the negative aspects of NIV is the mask (Lindahl,
Sandman, & Rasmussen, 2003; Torheim & Gjengedal, 2010). It has been expressed that
the mask can intensify anxiety by giving a sense of being trapped in it. This sensation
negatively affects breathing which, in turn, causes a sense of losing control over the
situation, inducing panic and irrational behaviour (Torheim & Gjengedal, 2010). In
addition, the foreign nature of the mask creates a sense of otherness (Lindahl et al., 2003;
Torheim & Gjengedal, 2010), indicating an escalated threat to their identity. Generally,
however, it is perceived that the burden of NIV is primarily a result of the psychological
disturbance generated by the implications of their need for a breathing assistance device
and the fear of being dependent on it: existential and independence threats (Lemoignan&
Ells, 2010; Lindahl et al., 2005; Lindahl, Sandman, & Rasmussen, 2006).
Decision-making
In contrast to the previous paternalistic approach inmedical intervention, a decision over
preference of care, including life sustaining treatment, is a joint decision between
clinicians and patients with the latter being the ultimate decision-maker in current
Western society. Gauthier and Swigart (2003) observed the decision-making in terminally
ill patients and report three determinants in decision-making process: realization of
terminality, accommodating living, and engagement with uncertainty. The first factor
refers to the degree of awareness of mortality that involves reflection on physical ability
and admitting to the changes. The second involves the realization of their needs and
adaptation to the changes. The last involves preparing for the unknown futurewith hope,
preparation, and anticipation. These three concepts were found to interact with each
other and work as assessment criteria to understand where individuals stand in the
decision-making setting. This model fits in with the findings of previous studies. For
example, Reid and her colleagues found that patients with cancer viewed opioid
treatment as the last straw and were resistant to it until the symptoms became too severe
to endure (Reid, Gooberman-Hill, & Hanks, 2008). This attitude towards opioids may be
understood as a wrestle between the acceptance of death and physical deterioration
(realization of terminality): an attempt to deny mortality by not taking opioids as this is
generally associated with being in the terminal phase. Johnson and Nelson (2008) also
observed denial of the reality to negatively affect decision-making by the dismissing of
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treatments, further supporting the model. And although there is a need for more
investigations to explore this argument, the importance of having a purpose in life as a
motivation for life (Chapple, Ziebland, McPherson, & Herxheimer, 2006) may be
explained using thismodel; the futurewithout a particular aim, or simply a lack of hope for
the future in the face of awareness of negative physical changes, is evaluated as pointless.
Such an attitude towards the future may be affected by a reluctance to adapt to changes
caused by disease, resulting in failing to generate adapted goals for the altered life.
In addition to the criteria proposed by Gauthier and Swigart (2003), the sense of
control and perceived quality of life have been recognized as other influential factors in
how people make decisions (Chapple et al., 2006; Lipsman, Skanda, Kimmelman, &
Bernstein, 2007). Chapple et al. (2006) argue that individuals may choose to actively
welcome euthanasia as a way of controlling their lives, while losing the control over their
body, and the right to make such a decision is seen as preserving one’s dignity.
Similarly, the decision regarding NIV use among people with MND is likely to be
dependent on their perception and evaluation of worthwhileness of their existence,
alongside a consideration of their physical deterioration and its psychological conse-
quences. Previous studies indicate that the decision-making process is a complex
procedure involving individuals’ evaluations of their physical condition, acceptance and
adaptation to the changes, and their sense of control and quality of life.
Current study
The aim of this research was to find the underlying reasons for why 30% of those offered
NIV treatment in our main study declined or withdrew from the treatment, and to gain an
in-depth understanding of a patient’s experience and decision-making processes around
an offer of NIV as part of treatment of MND.
Method
This investigation is a part of a larger prospective study (Ando et al., 2014; Cousins et al.,
2013). The aim of the larger study was to explore the experience of NIV treatment over
time inpatientswithMNDand their caregivers,which is being undertaken at twoNational
Health Service foundation trusts in North West England, United Kingdom. The study was
designed as a longitudinal study where patients and their caregivers were followed up
every 3 months from the time of referral to respiratory assessment until their death, or
withdrawal from research. All patients knew that the purpose of referral was to
commence respiratory monitoring in case NIV was required in future, and were aware of
the potential to use NIV inMND care. The larger study employedmixedmethods, and the
current article presents findings from the qualitative phase of the study.
Ethical concerns
All potential participants were given an information sheet providing full details of the
study, and assuring confidentiality and anonymity. Their right to decline or withdraw
from the study was explained, and it was emphasized that there would be no negative
effect on their treatment as a consequence of their decision. Consent was obtained once
patients agreed to take part. This study was approved by an NHS Local Research Ethics
Committee.
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Participants
Inclusion criterion for the main study was a confirmed diagnosis of MND based on El
Escorial criteria (Brooks, 1994); exclusion criterion was the presence of symptoms
indicating cognitive or behavioural dysfunction. NICE (2010) guidance was used for both
the timing of the referral to further respiratory assessments and for NIV initiation.
Potential participantswere identified by the respiratory teamwhen theywere referred for
respiratory assessments.
Thirty-five patients were enrolled into the main study. 10 patients did not take up NIV
treatment when it was offered based on physiological markers. One patient was
subsequently excluded from the analysis as the patient declined to talk in-depth about the
illness, limiting the sufficiency of the data. Of the remaining nine patients who provided
data for this research, seven patients undertook an NIV trial when it was offered; six
patients decided fairly quickly to withdraw from NIV; one patient (Henry) used NIV for
2 months before withdrawal from the treatment. Two patients did not try NIV treatment,
and both declined their respiratory follow-up appointment. Table 1 provides both
demographic and clinical information and data on the basis of recommendation made for
an initiation of NIV.
Data collection
Semi-structured interviews were employed to allow the researchers to be flexible in
exploring any interesting and relevant issuesmentioned by participants (Smith &Osborn,
2008). The interview schedule for the main study was developed by a multidisciplinary
team that consisted of one neurologist, two respiratory physicians, and one psychologist.
The interview schedule included exploring personal views of NIV treatment and
participants’ perception of the impact of NIV treatment over time. The first interviewwas
before trialling NIV; participants’ impressions, knowledge, and perceptions of both MND
and NIV (e.g., ‘When NIV was offered for your breathing, what were your thoughts?’)
were explored. Post-trial interviews then investigated their experience of NIV and their
decision to withdraw (e.g., ‘What was it like to use the ventilator?’). The length of
interviews varied between 20 min and 1 hr. The interviews were conducted at either at
the patient’s home or in hospital, according to the patient’s preference. Patients were
being interviewed on a regular basis by two researchers for the main study. The
Table 1. Demographic and baseline medical characteristics of the participants (n = 9)
Patient Age Onset
Bulbar at the
time of trial
Basis of non-invasive ventilation
recommendation
John 58 Bulbar Yes Nocturnal hypoventilation*
Matthew 79 Bulbar Yes Nocturnal hypoventilation*
Simon 71 Bulbar Yes Shortness of breath, Orthopnoea
Catherine 64 Limb Yes Nocturnal hypoventilation*
Henry 77 Limb Yes Nocturnal hypoventilation*
Peter 72 Limb Yes Mild breathlessness
Ian 71 Limb No Nocturnal hypoventilation*
Rachel 40 Limb No Nocturnal hypoventilation*
Ted 71 Limb No Orthopnoea
Note. *Measured by nocturnal pulse oximeter.
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researchers were known to be independent of the clinical care teams. Participants’
preference regarding the presence of their caregiver during their interview was
respected, although it was preferred to interview the person alone.
Interviews were normally conducted verbally. However, some strategies were
employed to mitigate communication difficulties with patients who had dysarthria
(e.g., communication by writing). The need for communication alternatives has been
previously argued and justified (Philpin, Jordan, &Warring, 2005). Interviewswere audio
recorded and transcribed verbatim except for interviews with John who did not want to
be recorded, and therefore, only field notes were available. This approach of recording
field notes is highly recognized in ethnography, where field notes may be the sole
accessible data (Palmer, 2010). In the same aspect, field notes were used in the current
research as the only data for John, who declined the formal interview, yet remained keen
to participate in the study. Although it may be argued that the analyses of John’s
interviews, or those with communication difficulties, should be excluded, the limited
number of people who fit into this sample category should be recalled. It was essential to
hear the views of this particular group of people on NIV treatment, albeit in this case,
through field notes rather than a verbatim transcript.
Pre-trial interviews were conducted with all nine participants; we were only able to
conduct post-trial interviewswith five patients due to death orwithdrawal from the study.
The first post-trial interviewswere used for analysiswith fivepatients. Post-trial interviews
were not available for four participants: two withdrew from the NIV trial and two
withdrew from both the trial and the respiratory service. The closest interview to the time
of trial, or declining from the trial, was analysed for those without a post-trial interview.
For Simon and Ian, two interviews were used as there was a change in interviewers
between those interviews. Including an additional interview in the analysis for these two
patientswas decided upon in consideration of the need to fully explore those participant’s
experience during the imperative period of time. Two interviews were also analysed to
better understand reasons behind declining NIV for John as only field notes were
available. Therefore, 5 pre-NIV interviews and 7 post-NIV interviewswere available giving
a total of 12 interviews for analysis. Medical data in relation to interviews and the timing of
the interviews are listed in Table 2. Although participants were recruited at the time of
consideration for NIV, the trial of NIV depended on results of their respiratory
assessments, and this resulted in variance in timing of interview visits.
Data analysis
As the aimof the studywas to understandunderlying reasons for unwillingness to useNIV,
an ideographic and phenomenological approach was considered most appropriate
method. Interpretative phenomenological analysis (IPA) was employed as it aims to
understand a particular phenomenon experienced by a particular group of people, yet
without losing the particularity of each participant (Smith, Flowers, & Larkin, 2009).
Through detailed examination of the phenomenon, as explained by the individuals, IPA
strives to identify the significance of the experience for the individuals, and this often
involves a small cohort (Brocki & Wearden, 2006; Smith et al., 2009).
The analytic steps described by Smith et al. (2009) were followed in the current
study. The analysis involved familiarization with the data, comprehensive annotation of
initial notes on the transcripts, and development of emergent themes. The themes were
arranged according to their relevance to the aims of the research and to their
significance in relation to reflecting participants’ lived experience of MND and NIV. A
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theme table was created containing both super-ordinate themes and their subthemes.
Individual analyses were first carried out, followed by broader generalizations of the
reasons for declining NIV treatment, in the context of MND, through exploring the
patterns across the cases.
Although the analysis was conducted by one researcher, rigour of the analysis was
achieved through peer examination (Krefting, 1991) with two other authors at two
separate points: at an early stage of the analysis and at the time of creating the theme table.
The peer examinations tested the credibility of interpretationof the quotes. The analysis is
also made transparent by the use of verbatim quotes in order that the credibility of the
analysis may be examined. It should be understood, however, that the interpretation
presented here is not the sole interpretation of the accounts.
Findings
A summary of the analysis is illustrated in Table 3. Four superordinate themes were
derived from patient narratives: preservation of the self, negative perceptions of NIV,
negative experiencewith health care services, and not needing NIV. These are elaborated
below with each of these themes described with an indication of their meaning for the
patient and illustrated by verbatim quotes from their narratives.
Preservation of the self: ‘it’s not really me anymore. . .’
Physical changes inMNDwere always mentioned by all of the participants as unavoidable
phenomena; however, the consequences of the changes were especially referred to by
four participants:
And as well, she didn’t shave me so I have no shave now and I hate that. I’ve always had a
shave every day of my life I have. I think that might be the worst thing about this motor
neurones. (Matthew, post-trial)
When talking about his caregiver, Matthew expressed his annoyance with her not
performing his previous ritual of ‘shaving’. Albeit a simple change in his daily activity, this
Table 2. Medical data in relation to interviews and NIV trial
Patient
Duration of MND
before NIV trial
(month)
Duration of MND
before interview(s)
(month)
Post-NIV trial interviews available Henry 1 3
Ian 27 25, 28
Matthew 17 17
Rachel 1 4
Ted 118 120
Deceased without post-NIV
trial interview
Catherine 14 12
Simon 16 10, 15
Declined from NIV trial John – 24, 28
Peter – 20
Note. MND, motor neurone disease; NIV, non-invasive ventilation.
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was perceived to be critical. This notion of curtailment of previous habits was further
linked with changed identity as noted by Simon:
I always used towear a shirt – had to. You know, had to be smart, take care, look good. Always
used to wear a shirt every day and have a shave and now I can’t. I have to wear tops without
buttons and I hate that. It’s not reallyme anymore because ofwhat I can’t do – the fiddly things
Table 3. Overview of analysis themes
Superordinate
theme Themes Subthemes Participants
Preservation of
the self
Identity Damaged identity Catherine, Matthew,
Simon
Preservation Autonomy Catherine, Matthew,
Simon
Dignity Catherine, Ian
Quality of life Ian, Simon
Breathing Significance of breathing Catherine, Simon
Autonomy of breathing Catherine, Simon
Negative
perceptions of
non-invasive
ventilation (NIV)
Features of NIV Mask
Sound Catherine, Simon
Alien Ian
Appearance and
practicality
Matthew
Claustrophobic Ian, Ted
Air Pressure Matthew, Ted, Rachel
Shocking
Psychological
reaction to NIV
Fear Matthew, Ted
Unbearable Ian
Threats to
autonomy
The loss of control Ian, Matthew, Ted, Rachel
Negative
experience with
health care
services
Impression of
hospital
Dislike of hospital Ian, Matthew, Ted
Poor image of hospital Ian
Bad interactions
with hospitals and
their anticipated
outcomes
Emotional damage
Withdrawal John, Peter
Rejection Peter
Confusion Ted
Disempowerment
Invaded autonomy Ian, Simon
Not needing NIV Symptoms and
perceived cause
Symptoms observed
Breathing Catherine, Ian, Matthew,
Simon
Sleep Ted, Rachel
Perceived cause
Different causations Catherine, Ian, Matthew,
Ted, Rachel
Chance Matthew, Ian
The need for NIV Solvable changes Catherine, Simon
Suspicious about the need Catherine, Ian, John,
Matthew, Ted, Rachel,
Simon
Terminal phase of the illness Henry
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like buttons. In business, it’s important, youknow, dress thepart –not like this, I hate this now
that I’m wearing. (Simon, pre-trial)
Even though his habit of wearing a shirt was described as compulsory, nevertheless,
wearing a shirt was a recognized part of Simon’s identity, which was now damaged
because of his physical restriction. The shirt was understood to be a ‘part’ of being a
businessman; thus, his previous habit of wearing a shirt was a crucial attachment to his
identity. Despite the fact that Simonwas no longer working in business, he still desired to
retain the previous normality, yet his physical impairments challenged this. This struggle
between their past and the new identity was a common observation, and the new identity
was generally perceived to be unacceptable:
I don’t want to just [long pause] fade away, just a helpless thing. That really is just the worst
thing that could ever happen to me; because, well, it must be hard for you to see it now
because you never knewwhat Iwas really like. But it’s not how I’ve livedmy life, like this, and
I’m just so sure that it’s not how Iwant to go out either. I want this all really to be over as soon
as it can be. I wouldn’t want to live much longer, and certainly I wouldn’t want people trying
to keep me alive longer than was natural – Longer than the disease wanted me alive. So, if
there’s nocure, I don’twant to bemessingwith anything else, youknow. (Catherine, pre-trial)
Catherine described how MND had damaged her life. MND had made her into a different
person distinct from her previous self. She questioned whether her impaired autonomy
diminished her quality as a human being. Her devastation over her current condition was
expressed in her depersonalization of herself as a ‘helpless thing’. It can also be
interpreted that the process of ‘fading’ of her physical body is also causing the ‘fading’ of
her sense of existence as a human. Catherine had little interest in ‘messing with anything’
in this context, which indicates her prioritizing the preservation of her dignity and her
sense of self. The concern for dignitywas prominent for all participants, and it related both
to theway ofmaintaining and of ending their lives. Ian uses an example of another patient
with MND to portray this point:
What’s-his-name, um, [MND patient] well, but look at the state he’s in. What kind of a life is
that? I mean his brain is still alright; that’s still alive, but that’s all though. (Ian, pre-trial)
Ian seemed to be suggesting that the quality of being consists largely in mobility, and it
may be further understood that the mere functioning of the brain without any mobility
does not count as a life as such, but just an existence. This points to the importance of
perceived quality of life, and mobility was the important aspect of quality of life for Ian.
The image of lifeless existence with the illness, either with or without cognitive
functioning, was also raised by other patients, and NIV was perceived to be a symbol of
such an existence.
I don’twant to end up like one of those peoplewho just lives hooked up to amachine. They’re
not really living, Iwouldn’twant it to be all of the time and not have any life.When I first heard
it [NIV] – that was what I thought. That was my first thought when I heard it. That’s what I’m
afraid of – if I start on that a little bit. [Long pause] I don’t want that. You can’t do anything.
(Simon, pre-trial)
Non-invasive ventilation presented an obstacle to having a life, and Simon claims that life
cannot be obtained while ‘hooked up’ to a machine. An impression of the loss of
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independenceor freedom tohave life once he starts usingNIVwas depicted. This imageof
reliance onNIVwas also captured by Catherine, referring to NIV as something to be relied
on for ‘the rest of your days’. Furthermore, the image of NIV was strongly related to the
end-of-life stage:
I remember his, um, he was really breathless almost all of the time in the end, towards the
end, and fighting, you know, really fighting to breathe sometimes actually – Hanging onto
life really I suppose. You know, despite all how he was the rest of him. That surprised me
actually. So, what I thought was that I didn’t want to end up like that gentleman in the home,
fighting for breath and clinging on to life like that. He was in my mind a bit. (Catherine,
pre-trial)
She expressed her surprise at the reaction of the patient with MNDwhowas desperate to
live, indicating her differing preference if she were in his position. Rather than
prolongation of life, her concern seemed to be the quality of life. For Catherine, life is not
worth fighting for when breathing is all that is left to her. Indeed, it was verbalized by
Catherine that ‘acceptability’ of status and ‘dignity’ were important aspects in her dying
process and NIV was negatively perceived in this context.
Personal perception of intervention with NIV: ‘. . .this is making me worse not better’
Some of the common reasons (n = 7) for withdrawal from NIV were the result of
participants’ perceptions of NIV treatment. Most participants expressed concern with
some features of NIV, such as the mask, yet with variance in the level of their concerns.
For Simon, this was addressed only briefly, indicating this to be a subordinate negative
aspect of NIV to him. Likewise, Catherine briefly mentioned her preconception of the
mask:
It’s scary having something like that on your face I think. And I’d imagine it’s quite
claustrophobic as well; yeah, just having to wear that thing – doesn’t sound very nice to me.
(Catherine, pre-trial)
Catherine raised a potential issue of the claustrophobic nature of the mask. This was also
an issue for Ted, as he elusively explained:
Ted: It’s just something I just. . .. itmight be something I am frightened of. I don’t knowwhat it is
– as though you trap something.
Interviewer: You trap something?
Ted: You know some people trap when they go into dark place or something like that.
People. . . what’s they – claustrophobia – I just don’t want it. I don’t want it on my face. (Ted,
post-trial)
There was no clear explanation for his claustrophobia, and his experience was confused
and emotional, as reflected in his poor articulation and the further observation that he
could not pin down the exact phenomena he was concerned about. The illustration of
being trapped, however, depicted the sense of insecurity and anxiety. As a result, he
simply stated that he did not want it. This somewhat impulsive reaction towards themask
was alsomentioned by Ian,who articulated the unbearable experience of having themask
on his face:
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I told [doctor] at first when I saw it I said, “no way that I can stick the mask onmy face”. I said
“Foreign” “Alien” I just couldn’t do it. (Ian, post-trial)
He described themask as ‘foreign’ and ‘alien’, expressing the impossibility of assimilation
with the mask. Moreover, Ian later referred to the mask as ‘KGB torture’, implying the
psychological and physical agony related to NIV.While the focus of these patients was on
the negative features of the mask, Matthew described his concern as below:
I don’t want to ruin it and I don’t want to feel sick. I didn’t actually be sick, but it made me
feel like I would be. So, I thought I wouldn’t use it – better not. I didn’t really like that. I
thought “Well, this is making me worse not better” that’s what I thought you see. (Matthew,
post-trial)
Even thoughMatthew did not actually vomit, his worry about being sickwith themask on
was enough for him to decline NIV treatment. Moreover, this fear of being sick convinced
him that NIV was actually making his health worse when he tried the machine at the trial.
Because of this fear, he was reluctant to pursue NIV use regardless of the fact that the trial
had taken place without him being sick.
The air pressure of NIV was also a cause of distress:
It was forced. . .. That’s what it’s like when it winds. It’s like, you know what I mean, I can’t
breathe [Became upset]. (Rachel, post-trial)
I definitely don’twant that again. It’s just [pause] as if it stoppedmebreathing; as though Iwas
trying to breathe out and thiswas blowing back and thewindwas blowing out [exhale]. (Ted,
post-trial)
Ted illustrated how asynchrony with NIV was experienced – as a fight to breathe. And
considering the significance of breathing, the NIV machine was seen to invade the
autonomy of his existence, and thus, he reacted against it. Based on this experience, Ted
showed no interest in trying NIV again regardless of his knowledge that NIV would
synchronize with his breathing pattern with acclimatization. This observation regarding
the fear of losing autonomy over breathing can be also applied to Rachel.
Negative experiences with the health care service: ‘they all forced on me. . .’
Six participants revealed their dilemma over working with the hospitals. Both John and
Peter reported receiving poor hospital service, and this was so influential that neither of
them would even consider a trial of NIV. Moreover, they later withdrew from continuing
with the study. This reluctance was already observable with John in his withdrawal from
the formal interview process and the field notes describe this:
When asked about breathing tests hewas reluctant to talk about them. He confirmed that this
was related to his experiences at the hospital when prompted. He said that this had not been a
very enjoyable experience for him and had put him off future visits. (John, pre-trial)
Likewise, Peter shared his encounter with the hospital:
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I was agreeable [to have breathing assessments] at first but every appointment since 2006 has
been cancelled. (Peter, pre-trial)
Peter reported to have been ‘let down’, ‘disappointed’, and ‘upset’ by the repeated
cancellations, which consequently dampened his initial willingness to attend the
assessments in consideration of NIV initiation. His response of rejectingNIVwas a response
to what he perceived as a previous rejection of his needs by the hospital. As a result, Peter
actively chose to disengage with the health care service altogether to prevent further
disappointment and the potential psychological distress this engendered. A similar
explanation may be applied to John’s behaviour, but for Ian, it was the image related to
hospitals that affectedhis senseof security that discouragedhim fromgoing through the trial:
I just really have never liked them [hospitals]. They are places where you gowhen bad things
happen really, aren’t they? You know, when you’re not well and people are dying and things.
So, I mean I just don’t like them. Never have. (Ian, pre-trial)
He showed his dislike of the idea of going into hospitals as an inpatient for a trial, for that
would imply that he was becoming one of the dying people. Despite having no actual
negative experience of hospitals, he reported that he had a ‘phobia’ of hospitals, which
appeared to have originated from an existential concern. Hence, Ian avoided hospitals to
protect his sense of mortality. Ian also described some negative interactions with medical
staff as a negative aspect of hospital service. He perceived a violation of his autonomy and
expressed frustration over the persistent approach of the hospital regarding NIV:
They’re trying to persuade me, yeah, very much so. I know they’re all at it, trying get me to
changemymind – even though really I think it’smy decision. And I have tried to tell them. I do
say the same thing every time I go there. (Ian, pre-trial)
Ian spoke about the persistent and forceful approach from the hospital regarding
potential NIV usage, and it was seen as an assault on his rights to make his own decision.
The hospital was preventing him from living his life as he desired; thus, the health care
service was seen to challenge his autonomy. A similar impression of intrusion into
autonomy was shared by Simon in terms of hospital appointments made for him:
I’m tired of it all already. And it’s going to get worse – I don’t need all of it. I wish they’d leave
me alone. If I haven’t [long pause] if I haven’t got long, I don’twant to spendmy time like that.
(Simon, pre-trial)
The sense of him having an overwhelming number of appointments was apparent. It was
interfering with his quality of life, and also it was creating a sense of loss of his autonomy.
More importantly, however, it was likely that his awareness of the ultimate outcome of
MND, being reflected by his silence, was the main reason for his desire to be left alone for
his limited time.
Not Needing NIV: ‘I don’t think I need it’
The majority of the patients (n = 7) were dubious about the need for NIV. Among them,
however, different reasons were identified for dismissing the idea. John witnessed no
change in his breathing.
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When questioned about his breathing, he felt that he had not experienced any change
in his breathing and was not having any problems at all. When questioned about the
previous symptoms at night mentioned by his wife, John denied knowledge of these. He
felt he had not had any problems. Although it was perhaps natural for him not to consider
NIV as he had no awareness of his breathing changes, his denial of hiswife’s account in the
interviewmay indicate his refutation of the symptoms. Even if hewas indeed not aware of
the event, he insisted that therewas no change in his breathing rather than taking notice of
his caregiver’s observation. Catherine experienced poor breathing, yet she still did not
perceive a need for NIV as it was not problematic:
Actually my own breathing is quite good; I do get slightly breathless if I have to do too much,
and if I get upset, but actually it doesn’t cause me any problems or any worry or any kind of,
um, it doesn’t upset me. I mean, I’m usually just sat here during the day or I’m in bed and it
doesn’t cause me any problems here or in bed, I’m quite comfortable in bed. I mean, the
reason I think they wanted to check my breathing was because I was having this little bit of
breathlessness. But since [doctor] has started me on these anti-depressants, actually it’s
almost completely gone. (Catherine, pre-trial)
Although Catherine acknowledged she had episodes of breathlessness, she showed little
concern about it and stated that it was actually ‘quite good’; her breathingwas not causing
her problems. Simon similarly admitted a change in his breathing, yet did not perceive a
need for support from NIV treatment:
I do occasionally [get short of breath]. But I have a spray for that, to help me if I feel my
breathing is slightly short. I have a spray for that. So, because I can use that, I don’t have any
concerns at all about my breathing really. (Simon, pre-trial)
Simon occasionally experienced more than mild breathlessness that needed addressing;
yet a spray originally prescribed for his asthma effectively cancelled the impact of
breathlessness; thus, he reported no concern over his breathlessness: his breathing was
recoverable and manageable. Other patients also shared their doubts:
I’ll try anything if it will help me. But the thing is that some days I’m alright getting out of the
chair and some days I struggle a bit. So I think “Do I really need a chair?” It’s like that a bit with
the breathing as well. Some days I feel better than others, so I think “Well, do I really need a
machine?” Because they did these overnight tests, but what if they were just one of my bad
days, and the rest of the time I could be alright, couldn’t I? So I don’t know about all these new
things coming to me. (Matthew, post-trial)
Even though Matthew showed his willingness to employ aids, he questioned their
necessity. He implied a conditional acceptance of the use of aids, indicating his resistance.
Also, his definition of good days and bad days, based on his experience of the days, is seen
to be superior to the overnight test presumably because of the daily assessment compared
with the one off assessment. This doubt regarding the credibility of hospital assessment
was held by other patients, with one patient even carrying out his own assessment for
confirmation:
Well, it’s [breathing] pretty stable. You know, it’s stable on that thing [peak flowmeter]. I’ve
taken a few this week and it’s been stable. (Ian, pre-trial)
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After being recommended to use NIV, Ian started his own breathing assessment with a
peak flow meter and the stable results gave him confidence in his breathing. For Ian, his
own measurements, taken on more than one occasion, confirmed that his breathing was
fine. In contrast to these patients whose arguments were based on their understanding of
their condition, Henry declined NIV after a medical consultation. In addition, Henry
appreciated the benefits of NIV and used it for some time until his condition dramatically
changed:
Now they’ve [doctors] told me that I don’t have to use it [NIV]. (Henry, post-trial)
In consideration of the progressive weakness outweighing the benefits of NIV, Henry
declined the treatment as it had stopped being effective and the focus of his treatmentwas
presumably changed from management of symptoms to the management of dying.
Overall hermeneutic circle
Although each superordinate theme derives from a different element of patient
experience leading to a rejection of NIV, a key driver was the maintenance of the self,
that is, the maintenance of autonomy, dignity, and quality of life. Firstly, the sense of self
was affected by the illness itself through the sense of losing control over the self due to the
illness. Consequently, patients became reluctant to engage with NIV, a treatment
identified as a further threat to self. Secondly, some features of NIV were perceived to
generate insecurity and impair quality of life. Needing themachine andmask interfacewas
perceived to challenge their autonomy. Furthermore, unpleasant interactionswith health
care services were perceived by some participants to be assaults against the self, causing
emotional distress and disempowerment to patients and, as a result, creating a general
desire in the participants to avoid interactionwith health care. Finally, the perception that
NIV was not necessary can be interpreted as an attempt to preserve identity and
independence by rejecting the idea of needing NIV.
Discussion
The aim of this study was to understand why some patients decline NIV, a potentially
life-extending treatment, when it is clinically indicated. IPA identified four themes:
preservation of the self, negative perceptions of NIV, negative experiences with health
care services, and not needing NIV. In this study, the term ‘self’ focused on autonomy,
dignity, and quality of life, whichwere identified to be influential in howpatients evaluate
their experience of using NIV. As mentioned earlier, we accept that the interpretation
presented here is not the only interpretation of the accounts and that others, including
those that interpret refusal of NIV as being due to the way it raises the threat of mortality,
may be possible.
Based on the model introduced by Gauthier and Swigart (2003), it is argued that the
participants in the current study were reluctant to engage with the treatment because
they were reluctant to admit their own condition and its consequences (realization of
terminality), and they were unwilling to adapt to the changes and accept the need for
help (accommodating living). The need for NIV was dismissed mostly because they did
not perceive their condition as problematic, if at all. It is interesting to note that most
participants acknowledged changes and to some extent accepted them, yet showed a
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reluctance to acknowledge them as a symptom of MND. It may be argued that this
tendency was related to their attempt to maintain the self, which had been damaged by
MND, rather than preparing for the unknown future (engagement with uncertainty).
Both control over the treatment and quality of lifewere also observed as important aspects
in decision-making process regarding NIV usage, and these are elaborated upon below.
The frustration over their new identity associated with their impaired independence,
as well as the fear of becoming dependent on NIV, was explicitly displayed by
participants. The health psychology literature provides evidence that disease can cause a
dramatic change not only biologically, but also psychologically (Dickson, Allan, &
O’Carroll, 2008; Harman & Clare, 2006; Williams, Moffatt, & Franks, 2004). An emotional
reaction to loss of independence and its impact on the way the self is perceived is seen in
various illnesses (Dickson et al., 2008). A common phenomenon after diagnosis is
appraisal of the situation through comparison with previous self or others (Harman &
Clare, 2006; Williams et al., 2004). Such a comparison may direct patients to preserve
those aspects of their self that disease cannot readily corrupt: their autonomy, dignity, and
some aspects of quality of life. Preservation of the self, in these terms, was clearly very
important to these patients and was a large part of declining and withdrawing from NIV.
Anxiety that NIV would be a threat was influential in decision-making. A significant
reason for withdrawal was inherent to the treatment itself (i.e., the mask and the forced air
pressure), and thiswasnot simply related tocomfort issues.Rather, theirnegative responses
to NIVwere generated as a result of fear and a reflection of their threatened autonomy. The
dominant negative feature of the mask expressed in the current study has been previously
reported as a cause of poor adherence to ventilation (Chasens, Pack, Malislin, Dringes, &
Weaver, 2005). Furthermore, irrational behaviour and a feeling of panic with the NIVmask
has been argued tobe themanifestationof anxiety and insecurity associatedwith the feeling
of being powerless and vulnerable in a given situation (Torheim&Gjengedal, 2010). In line
with this, high adherence to ventilation was found to be related to individuals with higher
self-efficacy (Wild, Engleman, Douglas, & Espie, 2004).
Poor impression of and interaction with health care services were found to challenge
the sense of self by causing emotional distress and disempowerment in the forms of
invading autonomy and the loss of control. Negative experienceswith health care services
were described in association with withdrawal from NIV, and indeed treatment of MND.
Participants described the overwhelming nature of appointments and persistent
persuasion to fall in line with the prescribed treatment, each serving to challenge
self-value. Previous negative experienceswere also perceived to have contributed to their
decision to decline further involvementwithhealth care services. ‘Devaluation’ generated
by health care services causes dissatisfaction, identity threat, and disempowerment in
patients (Coyle, 1999), which ultimately was addressed by patients withwithdrawal from
services leading to disengagement with formal health care.
The need for NIV was doubted by all but one patient. Some patients did not feel as
though they had sufficient symptoms to warrant a need for treatment. It is possible that
their breathlessness was covert due to a gradual adaptation to their respiratory changes as
found with chronic obstructive pulmonary disease (Gysels, 2008). Alternatively, some
individualsmay not see the need forNIV due to their confidence in their ability to improve
the problem (Prins, Verhaak, Bensing, & Meer, 2008). An attribution to a different
causation, such as finding an alternative explanation for breathlessness, is often observed
whenpeople try tomake sense of the experiences they are facing (Gysels, 2008;Horrocks,
Somerset, Stoddart, & Peters, 2004). Critically, this perception was linked with declining
or withdrawal from NIV.
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The important role the self played in the decision-making process in this particular
groupwas acknowledged. The detail of their negative responses toNIVdiffered, yet all the
accounts demonstrated that what mattered in their decision-making stemmed from the
same concern: maintenance of the self. This general finding reaffirms that an idiographic
approach reflected by hermeneutic practicewas crucial in understanding these particular
individuals in the particular setting of decision-making regarding NIV in the context of
MND.
Limitations of the study
The employment of the in-depth interviews enabled the researchers to understand
plausible reasons for NIV withdrawal, yet the limited number of post-NIV trial accounts
necessitates some caution. Although available post-NIV data from other patients showed
overall agreement with this analysis, additional themes may emerge from more post-NIV
interviews. Also, almost all of the data reported in this study were collected from patients
who had declined or withdrawn from NIV treatment at an early stage. Further studies
should include patients, who decline the treatment, from different stages of NIV use to
assess whether the reasons identified in the current study are still applicable. Studies
exploring how the concept of both identity and dependency issues are being dealtwith by
NIV users are also warranted.
Another limitation of the study is restricted verbal communication of some patients,
including John, who declined from a formal audio recorded interview. Inclusion of all the
participantswho declined the treatmentwas essential for the purpose of the study, yet the
rich information we were looking for was not available on account of this issue.
Conclusion
Just under a third of patients in the cohort we have followed did not wish to make use of
NIV. Given the proven survival benefit fromNIV, this was an unexpected observation, yet
not unique to this study. The main issues with NIV use were recognized to be how their
sense of selfwas perceived to be affected by the use, or potential use, ofNIV. Furthermore,
preservation of the self was not only perceived to be relevant in terms of NIV use, but also
in how they understood the phenomena of living with MND. The issues raised about
previous experience with health care services are salutatory for those involved with such
patients.
Based on the findings, we suggest that it is crucial to understand the psychological
dimension involved in decision-making regarding the use of NIV and would suggest a
sensitive holistic evaluation if NIV is declined. In addition, efforts could be made by
manufacturers of NIV equipment to take the tendency for claustrophobia into account by
finding designs that mitigate this reaction. Furthermore, it may even be possible for
designers to find a way of supporting identity despite the need to use the equipment.
Further work to determine whether supporting their sense of self would alter patients’
decision-making on NIV would be beneficial as services seek to improve their care to
individuals with MND.
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